Rating #134
Bernard Horn
Polaris Capital Management
Portfolio value
Stocks
Performance
1 Year
+11.82%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Bernard Horn’s Portfolio: Q4 2025
Top10 stocks: 42.59% of the portfolio
Bernard Horn’s Trades: Q4 2025
Adds
New Buys
Sold Outs
Cuts
0.10ppt
0.05ppt
0.06ppt
0.06ppt
0.04ppt
0.38ppt
0.05ppt
0.08ppt
0.06ppt
0.06ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  CVLG | +1061.04% | $20.96 | $1.09M | 0.10ppt | |
2  WNC | +88.20% | $8.73 | $591.89K | 0.05ppt | |
3  AMPH | +171.24% | $25.76 | $577.85K | 0.06ppt | |
4  WGO | +62.81% | $36.47 | $423.05K | 0.06ppt | |
5  EEFT | +100.00% | $77.96 | $420.98K | 0.04ppt | |
6  LKQ | +1.70% | $30.16 | $355.89K | 0.38ppt | |
7  BHB | +11.64% | $30.44 | $222.21K | 0.05ppt | |
8  ANF | +15.20% | $87.43 | $166.12K | 0.08ppt | |
9  BFST | +7.01% | $25.29 | $136.57K | 0.06ppt | |
10  NTB | +3.64% | $46.08 | $73.73K | 0.06ppt |
Bernard Horn’s Holdings: Q4 2025
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1  BPOP | State Commercial Banks | $39.89 | -23.03% | 682.33K | $84.96M | 7.05% -0.35ppt | 1.03% | 38 Quarters | Q4 2025 | |
2  JAZZ | Pharmaceutical Pres | $155.28 | -15.78% | 432.47K | $73.52M | 6.10% 1.65ppt | 0.71% | 19 Quarters | Q4 2025 | |
3  LIN | Inorganic Chemicals | $355.51 | -20.48% | 133.88K | $57.09M | 4.74% -0.52ppt | 0.03% | 12 Quarters | Q4 2025 | |
4  SW | Paperboard Containers | $53.86 | -16.93% | 1.45M | $55.98M | 4.64% -0.23ppt | 0.28% | 5 Quarters | Q4 2025 | |
5  UTHR | Pharmaceutical Pres | $193.42 | -15.08% | 103.65K | $50.50M | 4.19% 0.83ppt | 0.24% | 20 Quarters | Q4 2025 | |
6  MKSI | Industrial Instruments | $90.81 | -33.94% | 265.10K | $42.36M | 3.51% 0.25ppt | 0.39% | 24 Quarters | Q4 2025 | |
7  CVS | Retail-Drug Stores | $69.70 | -12.83% | 525.30K | $41.69M | 3.46% 0.47ppt | 0.04% | 21 Quarters | Q4 2025 | |
8  JPM | National Banks | $87.98 | -14.07% | 117.26K | $37.78M | 3.13% 0.31ppt | 0.00% | 38 Quarters | Q4 2025 | |
9  LNTH | Diagnostic Substances | $51.29 | -15.58% | 538.00K | $35.80M | 2.97% 0.82ppt | 0.80% | 2 Quarters | Q4 2025 | |
10  SLM | Personal Credit Institutions | $18.61 | -11.74% | 1.25M | $33.71M | 2.80% 0.23ppt | 0.60% | 16 Quarters | Q4 2025 | |
11  ARW | Wholesale-Electronic Parts | $85.17 | -12.32% | 295.40K | $32.55M | 2.70% 0.02ppt | 0.57% | 24 Quarters | Q4 2025 | |
12  GILD | Biological products | $62.81 | -15.14% | 265.10K | $32.54M | 2.70% 0.42ppt | 0.02% | 14 Quarters | Q4 2025 | |
13  WBS | National Banks | $39.31 | -14.97% | 516.20K | $32.49M | 2.70% 0.32ppt | 0.32% | 45 Quarters | Q4 2025 | |
14  IBOC | State Commercial Banks | $34.40 | -12.58% | 477.30K | $31.71M | 2.63% 0.16ppt | 0.77% | 45 Quarters | Q4 2025 | |
15  GD | Ship & Boat Building | $167.46 | -13.87% | 89.45K | $30.12M | 2.50% 0.17ppt | 0.03% | 45 Quarters | Q4 2025 | |
16  NOMD | Food Products | $16.06 | -32.32% | 2.33M | $29.14M | 2.42% -0.56ppt | 1.58% | 16 Quarters | Q4 2025 | |
17  CB | Casualty Insurance | $129.68 | -13.99% | 91.13K | $28.44M | 2.36% 0.39ppt | 0.02% | 40 Quarters | Q4 2025 | |
18  COF | National Banks | $87.23 | -15.83% | 115.04K | $27.88M | 2.31% 0.40ppt | 0.02% | 43 Quarters | Q4 2025 | |
19  TSN | Poultry Processing | $60.76 | -13.07% | 472.25K | $27.68M | 2.30% 0.36ppt | 0.14% | 35 Quarters | Q4 2025 | |
20  ABBV | Pharmaceutical Pres | $106.09 | -15.62% | 119.78K | $27.37M | 2.27% 0.11ppt | 0.01% | 23 Quarters | Q4 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.